BioLok

Osaka, Japan Founded: 1987 • Age: 39 yrs Acquired By HealthpointCapital
Products for Dental implantology and regenerative medicine

About BioLok

BioLok is a company based in Osaka (Japan) founded in 1987 was acquired by HealthpointCapital in September 2006. BioLok has raised $3.75 million across 2 funding rounds from investors including HHS, Radius Ventures and HealthpointCapital. BioLok operates in a competitive market with competitors including Convergent Dental, Neoss, Keystone Dental, Osstem and BioHorizons, among others.

Operational Areas
Key Metrics
  • Total Equity Funding
    $3.75M (USD)

    in 2 rounds

  • Latest Funding Round
    $3.75M (USD), Series A

    Mar 2005

  • Investors
    HHS

    & 2 more

  • Acquired by

Funding Insights of BioLok

BioLok has successfully raised a total of $3.75M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3.75 million completed in March 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $3.75M
  • Total Rounds 2
  • Last Round Series A β€” $3.75M
  • First Round $940,864

    (Nov 2003)

  • Investors Count 2

All 2 funding rounds of BioLok with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2005$3.75MSeries A––
Nov 2003$940,864Grant––
Valuation history

3 investors in total: 3 institutional.

Investors in BioLok

BioLok has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Radius Ventures and HealthpointCapital.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
-
–radiusventures.com-
HealthpointCapital is focused on private equity in musculoskeletal healthcare.
–healthpointcapital.comSan Diego, United States
Public health and human services are overseen by HHS.
1953hhs.gov-
Premium access

Investor details for BioLok

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of BioLok

1 people are tracked at BioLok (1 in leadership).

NameRoleGroup
Bruce L Hollander
CEOLeadership
Premium access

Complete people profiles for BioLok

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of BioLok

4 dated milestones of BioLok across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded BioLok is founded.
  2. Funding First funding round of $941K.
  3. Funding Latest funding round, Series A, of $3.8M.
  4. Exit Acquired by HealthpointCapital.

Competitors of BioLok

BioLok operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Convergent Dental, Neoss, Keystone Dental, Osstem and BioHorizons, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
convergentdental.com2011Natick, United States$116.1M89
Dental CO2 laser for soft and hard tissue application
neoss.com2000Harrogate, United Kingdom$30.01M147
Dental implant solutions are provided for patients and professionals.
keystonedental.com2006Burlington, United States$86.24M107
Dental implants and biomaterials are developed by Keystone Dental.
osstem.com2006Seoul, South Korea––
Dental implants and kits are manufactured and distributed by Osstem.
biohorizons.com1994Birmingham, United States$1.5M331
Dental implant technologies and tissue regeneration products are developed.
zestdent.com1972Carlsbad, United States––
Overdenture attachments and dental implants are developed and distributed.
nobelbiocare.com1952Zurich, Switzerland–98
Implant, prosthetic and regenerative solutions for dental markets
identicalimplant.com2018San Francisco, United States$8.2M–
Provider of a developer of personalized, drill-free dental implants that offers a safer, faster, and more affordable solution for tooth replacement compared to traditional dental implants
camlog.com2003Basel, Switzerland––
Products for implant dentistry and restorative dentistry
nasseo.com2012Peoria, United States$2.25M–
Nanotechnology for Medical Devices
Premium access

Detailed competitors of BioLok

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Similar companies to BioLok

10 companies that operate in the same segment as BioLok (Dental Disorders), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Custom 3D printed dental aligners are developed for teeth straightening.
2017New York, New York, United StatesUSD 147.78 M––
Invisalign clear aligners and dental products are developed.
1997Tempe, Arizona, United StatesUSD 101 M–1,051
Provider of 3D ear scanning systems
2000Copenhagen, DenmarkUSD 36.01 K–1
Dental implants and regenerative dentistry products are developed.
1954Basel, Basel-stadt, Switzerland–USD 3.29 B–
Optical equipment for micron-level surface geometry capture is offered.
2011Waltham, Massachusetts, United StatesUSD 16.22 M––
Dental implant solutions are provided for patients and professionals.
2000Harrogate, United KingdomUSD 30.01 M––
Dental implants and biomaterials are developed by Keystone Dental.
2006Burlington, Vermont, United StatesUSD 86.24 M––
Therapy devices and software for treating tooth decay are developed.
2006Laguna Hills, California, United StatesUSD 285.41 MUSD 28.55 M131
Invisible braces and oral care products are developed and provided.
2018Singapore, SingaporeUSD 55.1 M––
Implants for dental and spine treatments are developed.
2022Westminster, United States–USD 449.75 M1,770
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about BioLok

BioLok was founded in 1987 and raised its 1st funding round 16 years after it was founded.

BioLok is headquartered in Osaka, Japan. It is registered at Osaka, Osaka Prefecture, Japan.

Bruce L Hollander is the current CEO of BioLok.

BioLok is a funded company, having raised a total of $3.75M across 2 funding rounds to date. The company's 1st funding round was a Grant of $940.86K, raised on Nov 2003.

BioLok International (OTCBB: BLLI) develops and market products for the dental implant and tissue regeneration markets. BioLok is the worldwide manufacturer and distributor of the BioLok Precision Dental Implant System. In 2006, Biolok was acquired by Healthpoint Capital for 35M.

BioLok's top competitors include Neoss, Keystone Dental and Nobel Biocare.

BioLok has 3 investors. Key investors include HHS, Radius Ventures, and HealthpointCapital.

Yes. BioLok was acquired by HealthpointCapital in September 2006.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available